GTx, Inc. (GTXI)
(Delayed Data from NSDQ)
$1.14 USD
-0.01 (-0.87%)
Updated May 3, 2019 04:00 PM ET
After-Market: $1.17 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Oncternal Therapeutics, Inc. [GTXI]
Reports for Purchase
Showing records 1 - 20 ( 112 total )
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
ValuEngine Detailed Valuation Report for GTXI
Provider: ValuEngine, Inc
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Dropping Coverage Due to Realignment of Analyst Resources
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
GTx Refocuses on Enobosarm Breast Cancer Opportunity but at Significant Dilution Cost, Reiterate NEUTRAL rating and Reducing PT to $1 (from $2)
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of Nov 10
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of Sept 22
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of August 25
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of August 4
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
LIFE SCIENCES AND HEALTH CARE-The Week Ahead in Life Sciences - Upcoming Events for the Week of July 21
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of July 14
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of July 14
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Q1:14 Earnings, In Holding Pattern, Some Enobosarm Activity in Breast Cancer, Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
CEO Departs, European Strategy for Enobosarm Reaffirmed, Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
CEO Departs, European Strategy for Enobosarm Reaffirmed, Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Oncternal Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Q4:13 Results, PIPE Increases Runway, Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D